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JASON BENJAMIN WHEELER. Thoracic Aortic Aging and Smooth Muscle Cell Phenotype. (Under
the direction of JEFFREY JONES)
Background: The thoracic aorta undergoes structural and mechanical changes with age,
including dilation and increased collagen leading to decreased compliance. However, how agedependent changes in resident cells mediate this aging process is not well understood. Previous
studies have demonstrated a reduction in both ex vivo aortic contraction and in vitro collagen
gel contraction by aortic smooth muscle cells (SMCs) from old mice relative to young, suggesting
a deficit in aortic SMC contractility with age. Vascular SMCs are known to shift out of a
contractile phenotype, with disease or mechanical injury, to remodel the extracellular matrix
(ECM). Therefore, we hypothesized that aortic SMCs undergo a phenotype change with age that
contributes to aortic structural and mechanical changes with aging.
Methods/Results: Aortic SMCs were cultured from thoracic explants harvested from 6 month
(“young”, n=6) and 21 month (“old”, n=6) C57 mice. Phenotype was defined by assessing
proliferation, migration, adhesion, and gene expression. When measured over 7 days, old aortic
SMCs displayed reduced proliferation relative to young aortic SMCs. In a modified Boyden
chamber, migration by old aortic SMCs was reduced compared to young (13.4±1.0 vs. 28.8±4.8
migrated cells). Old aortic SMCs were less adherent to a poly-D-lysine surface after mechanical
washing relative to young (12.6±1.3% vs. 23.3±1.9% adherence). A PCR array was used to
measure the expression of ECM remodeling genes, including ECM proteins (collagens), matrix
metalloproteinases (MMPs), and tissue inhibitors of MMPs. Increased expression of these genes
produced a distinct genotypic profile in old aortic SMCs relative to young.
Conclusions: With aging, aortic SMCs exhibit reduced proliferation, migration, and adhesion.
Furthermore, old aortic SMCs have upregulated expression of ECM remodeling genes, including
collagens. Together, these results suggest that altered aortic SMC phenotype plays an active
role in aortic structural and mechanical changes with age.
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Introduction
The thoracic aorta undergoes many structural and mechanical changes with aging, including
dilation, increased collagen content, and increased stiffness. These age-related changes have
been increasingly recognized to adversely impact normal aortic function and may even affect
the risk of aortopathies, including aneurysm. In particular, increased aortic stiffness has been
identified as an independent risk factor for developing cardiovascular disease and clinical
guidelines on screening for aortic stiffness have been established. Interestingly, recent research
suggests that there may be overlapping signaling pathways involved in aortic aging and aortic
aneurysm. Considering the rapid growth of the elderly population, which will double in the next
20 years, there is a need for greater understanding of normal aortic aging processes. Most
reports of human aortic aging are limited to characterizations of histologic and stiffness changes
with age, with little description of changes at the cellular level or potential biochemical
mechanisms. Moreover, no non-transgenic animal model of aortic aging that recapitulates the
hallmarks of human aortic aging has been described in the literature, significantly hindering the
ability to study these aspects of aortic aging. Therefore, our objectives were to develop a nontransgenic mouse model of aortic aging and identify cellular and biochemical level changes
associated with aging. Accordingly, this thesis will review the research that established a nontransgenic mouse model of aortic aging, identified a novel age-related contractile deficit, and
implicated a phenotype shift in the aortic smooth muscle cell as a mediator of aortic aging.
Lastly, it will conclude with a discussion of future experimental steps to further elucidate the
mechanisms of aortic aging.
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Hypothesis and Specific Aims
HYPOTHESIS: Aortic SMCs undergo a phenotype shift with age that contributes to aortic
structural and mechanical changes with aging.

SPECIFIC AIM 1: Establish that aging is accompanied by ECM and cellular changes that directly
affect the compliance and contractility of the thoracic aorta. a) Examine aortic geometry and
wall structure by in vivo microscopy and histologic sections to demonstrate changes in aortic
diameter, wall thickness, collagen and elastin content, and cellular content with age. b)
Demonstrate impaired mechanical function of the aorta with age by measuring passive
compliance and active contractility ex vivo. In addition, determine the contribution of agerelated changes in aortic medial collagen and elastin content to passive compliance. c)
Demonstrate that aortic smooth muscle contractility is reduced at the cellular level using a
collagen gel contraction assay in the presence of a broad matrix metalloproteinase (MMP)
inhibitor.
SPECIFIC AIM 2: Demonstrate that aortic SMCs undergo a phenotype shift with age. a)
Establish smooth muscle cell phenotype is altered with age through in vitro assays for the
following parameters: proliferation, migration, adhesion, and gene expression. b) Demonstrate
increased aortic SMC expression of collagen and transforming growth factor beta (TGF-)
signaling pathway components.
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REVIEW OF THE LITERATURE

Chapter 1: The Aorta and Extracellular Homeostasis
Structural Anatomy of the Aorta
The thoracic aorta is a large elastic artery with a tri-layer wall composed of the tunica intima,
tunica media and tunica adventitia.[1] These three layers are divided by a sheet of elastin fiber,
the internal and external elastic laminae.[2] The functions of each layer are determined by its
endogenous components.[3] Proper function of each layer within the thoracic aorta depends
upon dynamic and tightly regulated homeostatic systems that preserve its microstructural
organization.[4] The tunica intima is the innermost layer and consists of a layer of simple
squamous epithelium, known as endothelium, affixed to a basement membrane resting on a
thin connective tissue matrix. Endothelial cells regulate the diffusion of solutes and water,
coagulation along the luminal surface, and transduce adrenergic stimulation. The intimal layer
extends from the luminal surface to an outer border lined by an internal elastic membrane that
marks the transition to the middle layer. The middle layer, or tunica media, is the thickest layer
and comprised of vascular smooth muscle cells (VSMCs), fibroblasts, collagen, several helical
elastic laminae and ground substance (a gel of glycosaminoglycans, glycoproteins and
proteoglycans). It is this middle layer that is predominantly responsible for the biomechanical
characteristics of the aorta. Alternating, concentric sheets of smooth muscle and elastin, known
as lamellar units, are intercalated radially by collagen and provide both distensibility and tensile
strength.[2] Medial lamellar content is greatest in the ascending thoracic aorta and decreases
by approximately one-half at the level of the abdominal aorta, progressively reducing the elastin
to collagen ratio.[2, 5] The tunica adventitia is the outermost layer that coats the media with a

3

thin layer of loose connective tissue made by fibroblasts, the primary cell type in the adventitia.
The adventitia functions as a fibroblast and stem cell progenitor reservoir, allowing rapid influx
of these cells into the aortic wall when needed (e.g. injury).[6] Traversing along the human
thoracic aorta within the adventitia are the vasa vasorum, which are smaller blood vessels that
penetrate into the thick media to supply nutrition beyond that provided by diffusion from the
luminal blood. Within this tri-laminar structure common to all arteries, the extracellular matrix
(ECM) and cellular components of the aorta interact and mediate normal aortic function.
Extracellular Matrix
The ECM is a vital network of supportive fibrous proteins that confers biomechanical strength
and organization to virtually every tissue within the body. Recent studies have revealed that the
ECM is not simply a passive scaffold onto which cells attach and move, but a dynamic regulator
of tissue growth and development. Within the aorta, the ECM is critical to withstanding the
range of blood pressures and shear forces acting on vessel walls. To maintain the structural
integrity of the vascular wall and properly regulate the behavior of its constituent cells, ECM
components are continually renewed by resident cells in a highly regulated process of
remodeling that delicately balances matrix protein deposition and degradation by proteases.
Dysregulation of these homeostatic systems can result in deleterious ECM remodeling, which
can impair normal aortic function. The two most abundant and studied aortic ECM components
in the settings of aneurysmal disease and aging are elastin and collagen.
Elastin is the most abundant ECM component in the aortic wall, forming as much as 50% of the
dry weight of the thoracic aorta.[7] During aortic development, VSMCs synthesize and arrange
concentric rings of elastic fiber around the arterial lumen.[8] Mechanical stretch or pressure
also stimulates elastin synthesis by medial VSMCs.[9] This macroaggregate fiber is secreted as
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soluble tropoelastin, stabilized by intermolecular cross-linking, and polymerized onto a preformed microfibril network. Elastic fibers allow the aorta to comply with increased
hemodynamic stress during systole, and through its recoil capacity, maintain sufficient diastolic
blood pressure.[10]
After elastin, collagen is the second most abundant ECM component within the aortic media and
adventitia. Collagen acts as the counterpart to elastin in that its tensile strength and stiffness
oppose the compliance of the elastic lamellae. Many types of collagen exist within the aortic
wall and may be categorized by their morphology into either fibrillar or non-fibrillar collagens.
Types I, II and III are fibrillar collagens and the predominant types. Types IV, V and VI are
nonfibrillar collagens and are major components of the endothelial basement membrane and
interstitial tissues, and are a primary component of the aortic adventitia.[11] The integrity of
the aortic wall is primarily attributed to collagen types I and III.[12] Thus, increased collagen
proteolysis due to an imbalance of synthesis and degradation would adversely affect aortic
integrity and indeed has been reported in human aortic aneurysms.[13]
Microfibrillar proteins also play significant structural and signaling roles that are essential to
normal aortic development and homeostasis. Microfibrils contribute significantly to aortic wall
integrity by acting to reinforce compliant tissues much like collagen. Fibrillins and fibulins are
the two main microfibrils in the aortic ECM. The role of fibrillin 1 (FBN1) in vascular physiology
is well described.[14] Fibrillins direct aortic morphogenesis during fetal development. Within
the adult aorta, fibrillin 1 interacts with collagen and elastin, forming a strong supportive
scaffold around an elastin protein core, and is essential for proper elastin organization. Recent
research on the role of FBN1 in the aorta has identified its crucial role in regulating the
sequestration and activity of various ECM and growth factors.[15] In particular, FBN1 levels
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modulate the bioavailability of transforming growth factor-beta (TGF-β), a major signaling
protein influencing vascular ECM remodeling.[16]
Vascular Smooth Muscle Cells
There are three primary cell types within the thoracic aortic wall: vascular smooth muscle cells,
fibroblasts and endothelial cells. Each of these types is capable of altering the aortic ECM
through production of proteolytic enzymes, ECM component proteins, and proteolytic
inhibitors. Thus, all of the cell types present in the aorta likely contribute to vascular ECM
homeostasis. However, VSMCs are the largest cell population by percent in the aortic media,
which is the layer which primarily determines the biomechanical properties of the aorta. Thus,
this cell type may exert the most influence over normal aortic function. VSMCs are capable of
both contraction and ECM protein synthesis. Smooth muscle cell contraction is involved in
several cell functions important in aortic wall homeostasis: cell shape and length, alignment and
migration. Additionally, the ability of these cells to synthesize, secrete, repair, and organize
ECM proteins (collagen, elastin and fibrillin) is vital to wall integrity. Thus, VSMCs are uniquely
equipped to regulate medial structure through both contraction and ECM synthesis. Through
direct interaction of VSMCs with various ECM proteins, these cells can integrate mechanical
stimuli into cellular (contraction) and extracellular (secretion) responses, remodeling the aorta
to meet current physiological demands and maintain normal function. For example, decreased
mechanical tension on VSMCs has been reported to alter multiple signaling pathways.[17]
Cumulatively, these studies exemplify the interdependent and interactive cell environment
within the aortic wall that may be disrupted in the context of aging.
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Extracellular Matrix Homeostasis
Vascular homeostasis maintains both the vascular ECM and its constituent cells in a
physiological state that maximizes the functional integrity of the aorta while adapting to
individual hemodynamic demands. Aortic ECM components confer mechanical stability and
hemo-propulsive elasticity to the aortic wall. Additionally, ECM components modulate the
bioavailability and activity of several growth factors, for example the pro-fibrotic transforming
growth factor-beta (TGF-β) signaling family. To achieve homeostasis, resident cells in the
thoracic aorta integrate and respond to a variety of mechanical inputs and biochemical signals
with alterations in cellular function including proliferation, migration, and ECM modification.
Thus, ECM structure and resident cells participate in a continuous feedback cycle. With respect
to the synthesis of ECM components, the transcriptional profiles of aortic wall cells must
preserve a delicate balance between deposition and degradation. Tightly regulated, alternating
cycles of synthesis and degradation, known as remodeling, are mediated by several families of
proteolytic enzymes and their endogenous inhibitors. An increase in expression of proteolysis
inhibitors could result in accumulation of ECM proteins, while an increase in expression of
proteinases would favor ECM degradation. Adaptive shifts in the relative abundance of these
mediators alter the structural composition and organization of the vascular ECM, in turn
influencing the phenotype of resident cells and vice versa. Changes in cellular phenotype are
therefore relevant to ECM homeostasis. Thus, understanding the regulation of aortic cell
phenotype may have significant implications toward therapeutically addressing age-related
alterations in aortic ECM homeostasis.
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Matrix Metalloproteinases
Matrix metalloproteinases (MMPs) are the most studied family of proteolytic enzymes involved
in ECM homeostasis and implicated in aortopathies, such as aneurysm. This family of
proteinases contains over 25 members with a wide range of target substrates, including virtually
all ECM proteins. All of the major cell types within the aorta are capable of producing MMPs.
The aortic ECM is directly degraded by these MMPs in response to growth factors (e.g.
transforming growth factor-beta, TGF-β), inflammation, oxidative stress, and matrix degradation
products. Elevated TGF-β signaling is associated with alterations in MMP expression and
activity.[18-20] All MMPs, except membrane bound MMPs, are secreted as proenzymes and
require proteolytic cleavage, in some cases by other MMPs, for their release and activation.[21]
To prevent cyclic MMP activation and unregulated proteolysis, a delicate balance of MMPs and
endogenous tissue inhibitors of MMPs (TIMPs) is maintained, as well as other pre- and posttranscriptional regulatory mechanisms. Indeed, the local balance of MMPs and TIMPs within
the aortic wall determines the overall effect on the vascular ECM, either deposition or
degradation. Somewhat paradoxically, increased MMP activity can release sequestered profibrotic factors, such as TGF-B, and result in ECM accumulation.
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Chapter 2: TGF-β Signaling is Increased in Aging and Aortopathies
“Canonical” TGF-β Signaling Pathway
Transforming growth factor-β is a soluble cytokine secreted by cells in the form of a large latent
complex (LLC) composed of a homodimer of mature TGF-β peptide, a homodimer of TGF-β’s
inactive cleaved peptide fragment (latent associated protein, LAP), and latent transforming
growth factor binding protein (LTBP).[22] Motifs within fibrillin-1 interact with LTBP and target
the LLC to the ECM.[23] Thus, the ECM serves to sequester and concentrate TGF-β in locations
where it may be rapidly activated when needed.[24] Indeed, the ECM is no longer thought to be
a passive structural support but rather a dynamic regulator of growth factor bioavailability and
signaling.[25, 26]
Mature TGF-β (types 1–3) is activated by release from the LAP through multiple mechanisms
including: direct proteolysis, by non-proteolytic dissociation mediated by thrombospondin-1 or
integrin αvβ6, as well as exposure to reactive oxygen species, or low pH.[27] Once activated,
TGF-β predominantly forms homodimers that can now interact with and bind a TGF-β receptor
in the first step of the signaling cascade.[22] Transforming growth factor-β receptors have been
subdivided into three types. Type-I (also known as Activin receptor-like kinase 5/ALK-5 or
TGFBRI) and type-II are the primary receptors of the classical - or “canonical”-pathway and both
possess serine/threonine kinase activity. Type-III (also known as betaglycan) is an accessory
receptor that binds TGF-β and presents it to the type - I and II receptor complex.[22] Other
receptors that bind and signal in response to TGF-β include endoglin (type-III receptor) and the
Activin receptor-like kinase 1(ALK-1), a type - I receptor family member.
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After release from the ECM, mature TGF-β first binds a homodimer of the type-II receptor
inducing an autophosphorylation event. This, in turn, recruits a homodimer of the type - I
receptor forming the complete ligand-receptor complex. The type-II receptor then activates the
type - I receptor via transphosphorylation.[28] The kinase domain of the activated type - I
receptor propagates the intracellular signal through the phosphorylation of specific receptorregulated Smad proteins (R-Smads; Smad 1, 2, 3, 5, and 8), which are the second messengers of
the canonical TGF-β signaling pathway. For example, activation of the type - I receptor TGFBRI,
results in the phosphorylation of Smad 2 or 3; while activation of the type - I receptor ALK-1
results in the phosphorylation of Smad 1, 5 or 8. The choice of Smad is likely tissue-specific and
context-dependent. The phosphorylated R-Smad then interacts with a common Smad or “coSmad” (Smad4), which induces translocation of the complex to the nucleus. The nuclear Smad
complex along with multiple co-regulatory factors form a transcription regulating complex
capable of activating or repressing TGF-β associated genes [29, 30] (Figure 2.1). Activation of
the TGF-β system stimulates a number of diverse cellular processes, such as cell growth,
proliferation and apoptosis and therefore requires strict regulation at multiple levels. An
example of this regulation, is the negative feedback of inhibitory Smads (I-Smads; Smad6 and 7)
induced by TGF-β stimulation.[31] Smad6 exerts its effects by binding directly to type - I
receptors and blunting R-Smad phosphorylation.[32] Smad6 also inhibits signaling by competing
with Smad4 for receptor Smad binding sites, reducing nuclear translocation.[33] Smad7 inhibits
TGF-β signaling by targeting TGFBRI and II for ubiquitination and subsequent degradation,
through the recruitment of Smurfs 1 and 2 (Smad ubiquitination regulatory factor 1 and 2).[3436] Additionally, many regulatory proteins influence the bioavailability of TGF- β, such as the
structurally related scavenging proteoglycans decorin and biglycan, which bind and reduce its
availability for signaling.[37-39]
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TGF-β Signaling in Aneurysm and Aging
Recent research suggests that TGF-β signaling is involved in aortic aneurysm and aortic aging.
Marfan syndrome (MFS) and Loeys-Dietz syndrome (LDS) are well described heritable disorders
characterized by connective tissue defects and aortic aneurysms.[40] A mutation in fibrillin-1
(FBN1), a protein component of microfibrils, accounts for more than 90 % of MFS.[41] Fibrillin-1
was demonstrated through multiple studies to interact with and sequester latent transforming
growth factor-beta (TGF-β) within the extracellular matrix (ECM) [3 –6]. In 2003, Neptune et al.
hypothesized that the loss of microfibrils may have an effect on the sequestration of TGF-β
within the ECM and demonstrated that TGF-β signaling was markedly activated within lung
tissue of a mouse MFS model.[42] Furthermore, the emphysematous lung phenotype of the
MFS mice was restored to wild type with anti-TGF-β antibody, strongly suggesting that TGF-β
signaling dysregulation contributed to the pathogenesis of MFS.[42] Subsequently in 2005,
Loeys and Dietz identified mutations within type-I (TGFBRI) or II (TGFBRII) TGF-β receptors in a
cohort of patients with a phenotype similar to MFS but without FBN1 mutations.[43]
Interestingly, despite mutated receptors incapable of propagating signal, patients with LoeysDietz syndrome (LDS) paradoxically exhibited indications of increased TGF-β signaling: increased
expression of collagen and connective tissue growth factor (CTGF), similar to MFS patients.[43]
Interestingly, dysregulation of TGF-β signaling and MMPs has been reported in the context of
aortic aging. Wang et al. described increased MMP-2 mediated TGF-β signaling using aged rat
aortic homogenates and immunostaining, in association with increased aortic collagen
content.[44] Furthermore, in vitro studies implicated the aortic SMC as the cell type responsible
for TGF-β activation. Increased MMP-2 activity with age has also been reported in primate and
human aortas.[44-46] Therefore, normal aortic aging processes could result in an aortic
substrate more susceptible to aortopathies, particularly aneurysm.
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Functional and Cardiovascular Risks Associated with Aortic Aging and Aortopathies
Both aortopathies and normal aortic aging are associated with impaired aortic function, which
may also impact cardiovascular disease risk. One functional change associated with both aortic
aging and aortopathies is decreased compliance.[4] The compliance of the aorta allows it to
distend during systole and briefly store a majority of the stroke volume. Elastin lamellae store
some of the ventricular contraction energy, which through elastic recoil, modifies the pressure
pulse generated by the left ventricle into continuous flow to the peripheral circulation,
simultaneously maintaining adequate diastolic blood pressure.[47] Among the aortic branches
dependent upon this recoil force are the coronary arteries, which conduct the majority of their
blood flow during diastole when the aortic pressure exceeds the ventricular pressure,
particularly to the left ventricle. Unfortunately, decreases in aortic compliance negatively affect
both diastolic and systolic blood pressure.[47] The normal aorta counters falling diastolic blood
pressure due to peripheral run-off with elastic recoil that adds stored stroke volume thereby
sustaining consistent diastolic pressure. Thus, diastolic pressure falls rapidly in the setting of a
non-compliant aorta. Moreover, without the storage of blood volume within a compliant aorta,
this volume is immediately conveyed systemically, adding to systolic pressure. The abnormally
increased difference in systolic and diastolic pressure, known as pulse pressure, is a risk factor
for coronary artery disease and contributes to increased cardiac workload.[48] Combined with
the potential for reduced coronary perfusion pressure during diastole, reduced aortic
compliance with age may increase cardiac oxygen demand, reduce output and predispose to
cardiovascular disease.[49]
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Significance of Age-Related Research and Aortic Changes with Age
Current population projections suggest that life expectancy is increasing as well as the median
age of our population. This is driven in part by the “Baby Boomer” generation, who started
reaching 65 years of age in 2011. In the next 20 years, the number of people in the United States
over 65 years old, the average age of diagnosis with a thoracic aortic aneurysm, is expected to
double.[50, 51] Therefore, research on normal aortic aging processes is increasingly relevant and
may significantly inform future therapeutic approaches for aneurysm.
It has been well described that aging is associated with changes in human aortic geometry, even
in the absence of aortopathy and cardiovascular risk factors such as hypertension.[52-54]
Redheuil and colleagues reported an age‐dependent increase in the diameter and thickness of
the human thoracic aorta in healthy patients.[55-57] This dilation, according to the Law of
LaPlace, would increase wall stress even without increases in blood pressure, suggesting
perhaps that increased thickness with age is a compensatory response to increased wall stress
and when insufficient may contribute to aneurysm risk.[58] Furthermore, aging is known to be
associated with fibrosis in a number of organs including the aortic wall.[59, 60] In particular, an
increase in collagen content has been reported to occur in aortas from older subjects even in
the absence of hypertension, which due to the mechanical properties of collagen is believed to
contribute to increased aortic stiffness or reduced compliance with age.[61-63] Although total
elastin content has been reported to be similar in aortas from young and older human subjects,
the abundance of elastin relative to other ECM components is reduced in the aortas from old
subjects.[61, 64] In addition, the organization of ECM components within the aorta has been
reported to decrease with age and perhaps contribute to stiffness.[65, 66] Interestingly,
alterations within the aortic ECM may initiate inflammatory and calcification process that can
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also influence vascular stiffness.[67] Changes in SMC phenotype have also been reported in
association with age-related alterations in the aortic ECM, suggesting these cells may mediate
aortic aging.[68] Together, these age-related changes in the structure and composition of the
aorta, in association with changes in SMC phenotype, impair normal function and may also
contribute to an aortic substrate that is more susceptible to aortopathies, including aneurysm
and rupture.[69, 70]
However, relatively little is known about the mechanisms behind aortic aging. It is not well
understood which cell types play critical roles in aortic aging process and how these cells are
altered with aging. Within the aortic literature, the majority of reports of human aortic aging
are limited to characterizations of histologic and stiffness changes with age, with little
description of changes at the cellular level or potential biochemical mechanisms that produce or
contribute to these age-related changes. Moreover, no non-transgenic animal model of aortic
aging that recapitulates the hallmarks of human aortic aging has been validated in the literature,
significantly hindering the ability to study these aspects of aortic aging. Therefore, our
objectives were to develop a non-transgenic mouse model of aortic aging and identify cellular
and biochemical level changes associated with aging.
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EXPERIMENTAL METHODS, RESULTS AND DISCUSSION

Chapter 3: Methods Establishing a Model of Aortic Aging and Measuring Contraction
Overview
The goals of this study were to determine the effects of age on the geometry, the cellular and
ECM composition, and the relationship between ECM composition and mechanical
characteristics of the thoracic aorta.
Animals
All procedures were performed in accordance with the National Research Council's Guide for
the Care and Use of Laboratory Animals (2012) and approved by the institutional animal care
and use committee of the Medical University of South Carolina. C57BL6 wild‐type male and
female mice (N=103, 50 male, 53 female) aged 6 (n=55) and 21 (n=48) months were obtained
from the National Institute on Aging mouse colony at Charles River Laboratories International
(Wilmington, MA, USA). Equal numbers of male and female mice were used in each study. Old
mice were heavier than young mice (33.5±0.9 versus 28.5±0.8 g; old, n=38; young, n=42). Tibia
length was measured with a digital caliper after incubating 48 hours in 2 mol/L potassium
hydroxide and was similar between the old and young groups (18.2±0.1 mm versus 18.0±0.2
mm; old (n=9) versus young (n=19), respectively).
In-Vivo Aortic Diameter Measurement
Anesthetized mice (2% isoflurane) were intubated and mechanically ventilated.[71] A left
posterolateral thoracotomy was performed at the sixth intercostal space. Images of the exposed
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descending thoracic aorta were captured on a calibrated video microscopy system (PAXcam
using PAX‐it software version 7.6; MIS Inc) and then were used to measure external aortic
diameter, as described previously.[71]
Histology and Quantitative Analysis
Descending thoracic aortas from young (n=10) and old (n=10) mice were harvested from the
level of the eighth rib to the diaphragm and fixed in 10% formalin for 48 hours and then
transferred to 70% ethanol for storage at 4°C. Fixed aortic segments were embedded in paraffin
and sectioned at 2‐μm thickness. Sequential sections were stained with picrosirius red for
collagen, Verhoeff‐Van Gieson for elastin, and hematoxylin and eosin to visualize cell nuclei for
quantification. Aortic tissue sections were visualized on a Zeiss Axioskop 2 microscope (Carl Zeiss
MicroImaging), and digital images were acquired (Axiocam MRc camera and AxioVision
software, version 4.8). All quantitative image analysis was performed using SigmaScan Pro
version 5.0 (Systat Software Inc) and Adobe Photoshop CS5 (Adobe). For each study, analysis of
histology sections was performed using at least 3 randomly chosen high‐power fields from 3
different sections from each young (n=10) and old (n=10) mouse. Aortic medial thickness was
measured from the internal elastic lamina to the adventitial border. Aortic lumen perimeter was
calculated by summation of the edge lengths of a digital overlay filling the vessel lumen.
Collagen and elastin volume fraction in the medial layer was determined as the ratio of the area
stained by picrosirius red and Verhoeff‐Van Gieson stain, respectively, divided by the total area
of tissue within each high‐power field. The volume fraction of thin (green–yellow birefringence)
and thick (red–orange birefringence) collagen fibers was measured in picrosirius red–stained
sections illuminated by polarized light. Cell density (in cells/mm2) in the medial aortic wall was
calculated by counting the number of nuclei in 0.0023‐mm2 areas of medial tissue from 3
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sections from young (n=10) and old (n=10) mice and dividing by the total area of tissue
examined.
Aortic Ring Preparation and Measurement of Passive Tension
Descending thoracic aortas from young (n=25) and old (n=24) mice were harvested and
immediately placed in cold Krebs‐Hanseleit buffer (118 mmol/L NaCl, 4.6 mmol/L KCl, 1.2
mmol/L KH2PO4, 25 mmol/L NaHCO3, 2.5 mmol/L CaCl2, 0.5 mmol/L Na2‐EDTA, 11 mmol/L
glucose, 1.2 mmol/L MgSO4, pH 7.4). The endothelium was removed by gently rubbing the
intimal surface to mitigate any potential endothelial effects on medial contractility.[72] The
aorta was divided into 3‐mm‐long segments (typically 2 segments per mouse) that were each
mounted on parallel wires in a water‐jacketed tissue bath system (25 mL; Radnoti LLC)
maintained at 37°C and connected to an isometric force transducer (Radnoti).[73] The vessels
were allowed to equilibrate for 30 minutes in the absence of tension and washed every 15
minutes with warm Krebs‐Hanseleit solution aerated with 95% O2 and 5% CO2.
Tension was applied by gradually separating the parallel wires, as described previously.[74] The
Krebs‐Hanseleit solution was supplemented with EGTA (5 mmol/L) to minimize calcium‐induced
SMC contraction. Stress relaxation was quantified by sequentially stretching vessel segments in
0.1‐g increments (from 0.2 to 1.2 g of applied tension) and measuring residual tension after 3
minutes to calculate the percentage of relaxation. Measurements were recorded using Biobench
software (National Instruments). Stress relaxation values were normalized to wall thickness for
comparison of differently sized segments.
Determination of Aortic Contractile Properties
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To determine contractile properties, the aortic rings harvested from young (n=14) and old (n=8)
mice were equilibrated with an applied tension of 0.4 g for 30 minutes in standard Krebs‐
Hanseleit buffer without EGTA. Contraction was stimulated by adding KCl (final concentration of
100 mmol/L in the bath), and the peak contractile force (in grams) generated over the ensuing 8
minutes was recorded. The rings were washed 3 times with fresh Krebs‐Hanseleit solution to
remove residual KCl. These steps were repeated at 0.1‐g increments up to 1.2 g of applied
tension, as described previously.[73] To control for differences in ring tissue mass between
young and old mice, the peak contractile force was normalized to aortic ring volume,
determined from aortic diameter and wall thickness.
Smooth Muscle Cell Isolation
Primary SMCs were isolated using an outgrowth procedure in which minced pieces of aorta from
young and old mice (6 young, 6 old) were plated in SMC‐specific growth medium (C22062;
PromoCell) and allowed to extravasate for 2 weeks. After 2 weeks, the pieces of aorta were
removed, and the SMCs were maintained in culture. Cells in passages 3 to 7 were used for all in
vitro experiments.
Collagen Gel Contraction Assay
Equal numbers of SMCs (50 000) were embedded in disks of rat tail collagen type I (1 mg/mL in
SMC growth medium; Gibco) polymerized in a 24‐well nontissue culture‐treated plate in the
presence of broad‐spectrum matrix metalloproteinase inhibitor GM6001 (25 μmol/L final
concentration; Millipore). Disk area was measured from digital images collected at 0, 3, 6, 9, 12,
18, and 24 hours. Contraction was expressed as a percentage of baseline area at time 0.
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Statistical Analysis
All results are presented as mean±SEM. The Student t test was used to compare measurements
of aortic geometry, histology, and peak active tension between young and old groups.
Repeated‐measures ANOVA was used to compare passive tension and collagen gel contraction
between experimental groups. If ANOVA revealed significant differences, post hoc mean
separation was performed using Tukey's wholly significant difference test. The relationships
between the abundance of ECM components and aortic mechanical properties were established
using linear least‐squares regression analysis. All statistical analyses were performed using Stata
statistical software (version 8, intercooled; StataCorp). P values of <0.05 were considered to be
statistically significant.
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Chapter 4: A Mouse Model of Aortic Aging and a Novel Contractile Deficit with Age
Introduction
The thoracic aorta is a large elastic artery with functionality beyond a static, passive conduit.1
Functions of the aorta include regulating systolic blood pressure by accepting the ejection bolus
through expansion and maintaining diastolic blood pressure by dynamic, elastic recoil.[75, 76]
Consequently, normal functioning of the aorta requires consistent passive and active mechanical
properties, which include compliance and contractility.[77] Vessel compliance is generally
considered to be related to the composition of the extracellular matrix (ECM).[75] Two ECM
proteins in particular, collagen and elastin, provide the aortic wall with tensile strength and
elastic recoil and contribute to maintaining compliance properties of the aorta.[78] Aortic
contractility is reflected by the contractile force generated primarily by vascular smooth muscle
cells (SMCs) and provides the active tension component within the aorta.[79] Together, the
extracellular and cellular components regulate mechanical properties within the aorta and,
when altered, could contribute to vascular pathophysiology.[80]
The precise roles of these age‐related changes in altering aortic mechanical function are not well
understood. Accordingly, this study used young and old mice to establish that aging is
accompanied by ECM and cellular changes that directly affect the compliance and contractility
of the thoracic aorta.
Results
Thoracic Aortic Diameter and Medial Thickness With Aging
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Thoracic aortic diameter, measured in vivo, was significantly greater in the old mice than in
young mice (Figure 4.1A). The aortic medial layer, measured from histological sections (as
shown in representative photomicrographs in Figure 4.1B), was significantly thicker in old mice
than in young mice. In addition, lumen perimeter was greater in old versus young mice (Figure
4.1C). Together, these results suggest that an age‐dependent increase in aortic diameter was
the result of both dilation and increased wall thickness.
Medial Extracellular Matrix and Cellular Changes With Aging
Representative picrosirius red–stained sections in bright‐field illumination are shown in Figure
4.2A (top panel). Quantification of the amount of staining from these sections revealed that
collagen volume fraction was increased in the old group, as summarized in Figure 4.2A (bottom
panel). To assess collagen fiber characteristics, picrosirius red–stained sections were illuminated
in polarized light (Figure 4.2B, top panel). The thin fibers show birefringence in the green–yellow
spectrum, whereas the thick fibers are birefringent in the orange–red spectrum.[81] The medial
volume fraction of thin collagen fibers and thick collagen fibers were both increased in the old
group compared with the young group (Figure 4.2B, bottom panel). To examine the elastic
architecture, aortic sections from young and old mice were stained with Verhoeff‐Van Gieson
(Figure 4.2C, top panel). The medial elastin volume fraction was not different between young
and old mice (Figure 4.2C, bottom panel). To determine cellular density, hematoxylin and eosin–
stained aortas from young and old mice were examined and nuclei were counted (Figure 4.2D,
top panel). The density of cells in the medial layer was significantly lower in the aortas from old
mice compared with young mice (Figure 4.2D, bottom panel).
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Figure 4.1 Thoracic aortic diameter, wall thickness, and lumen perimeter with age. A, In vivo
aortic diameter (in micrometers) was increased in old mice (n=14) compared with young mice
(n=12). B, Representative histology showing full thickness of thoracic aortas from young mice
(left) and old mice (right) stained with picrosirius red. Scale bar=20 μm. Aortic wall thickness was
greater in old (n=10) versus young (n=10) mice. C, Aortic lumen perimeter was increased in old
mice (n=8) relative to young mice (n=8). *P<0.05 vs young.
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Figure 4.2 Thoracic aortic structure and composition changes with age. The structure and
composition of the aortic medial layer were compared between young (n=10) and old (n=10)
mice using histological staining. A, Representative images of collagen stained with picrosirius red
viewed under bright‐field light in young (left) and old (right) mice. Scale bar=25 μm. Collagen
volume fraction was increased in old mice relative to young mice. B, Representative images of
collagen stained with picrosirius red viewed under polarized light in young (left) and old (right)
mice. Scale bar=25 μm. The volume fraction of thin collagen fibers (green–yellow birefringence)
was increased in old mice relative to young mice (left graph). Similarly, the volume fraction of
thick collagen fibers (red–orange birefringence) was increased in old mice relative to young mice
(right graph). C, Representative images of elastin stained with Verhoeff‐Van Gieson in young
(left) and old (right) mice. Scale bar=75 μm. Elastin volume fraction was not different between
young and old mice. D, Representative images of aortic sections stained with hematoxylin and
eosin (red/pink indicates cytoplasmic and extracellular proteins, black/blue indicates nuclei) in
young (left) and old (right) mice. Scale bar=15 μm. The total number of nuclei, equivalent to
medial cellularity, was reduced in old mice relative to young mice. *P<0.05 vs young.
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Thoracic Aortic Compliance Declines With Age, Correlates With Medial Collagen Volume Fraction
but Not With Medial Elastin Volume Fraction
Alterations in the relative abundance of medial ECM proteins may be expected to alter the
passive mechanical properties of the thoracic aorta. Accordingly, stress relaxation was measured
in aortic rings of young and old mice as a direct indicator of aortic compliance. The results
demonstrated that aortic rings from old mice were less compliant than rings from young mice,
indicated by the downward shift in the relationship between applied tension and stress
relaxation (Figure 4.3A). As one may expect, stress relaxation was negatively correlated with
collagen volume fraction (r=−0.6206, P<0.05) (Figure 4.3B). There was no correlation between
stress relaxation and elastin volume fraction (r=0.2824, P was not significant) (Figure 4.3C).
Thoracic Aortic Contractility With Aging
Peak contractile force was used to compare thoracic aortic contractility between young and old
mice.[73] Peak contractile force normalized to aortic tissue volume (Figure 4.4) was reduced in
aortic segments from old mice compared with young mice.

24

Figure 4.3 Mechanical properties of young and old aortas. A, Stress relaxation normalized to wall
thickness was decreased in old mice (n=24) relative to young mice (n=24). B, Stress relaxation
normalized to wall thickness is negatively correlated with collagen volume fraction; correlation
coefficient, R, and P value of linear regression are shown. C, Stress relaxation normalized to wall
thickness was not related to elastin volume fraction; correlation coefficient, R, and P value of
linear regression are shown. *P<0.05 vs young.
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Figure 4.4 Aortic contractility decreases with age. Peak contractile force normalized to tissue
volume was reduced in old mice (n=8) relative to young mice (n=14). *P<0.05 vs young.
Smooth Muscle Cell Contraction of Collagen With Aging
The collagen gel contraction assay was used to determine whether the reduced peak contractile
force observed in aortas from old mice was due to age‐related changes in the contractile
phenotype of aortic SMCs (ASMCs) or just due to a decrease in overall medial cellularity.
Isolated primary SMCs from young and old mice were examined in the presence of a global
matrix metalloproteinase inhibitor. Collagen disks seeded with AMSCs isolated from young and
old mice displayed a time‐dependent reduction in area over the 24‐hour duration of the assay
(Figure 4.5). Gel contraction mediated by ASMCs from old mice was significantly reduced
compared with ASMCs from young mice (repeated‐measures ANOVA, F=133.875, P<0.05). In
comparison, the reduction in disk area at and after the 6‐hour time point was significantly
attenuated in ASMCs isolated from old versus young mice (Figure 4.5).
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Figure 4.5 Collagen gel contraction by aortic smooth muscle cells decreases with age. Collagen
gel contraction in the presence of the matrix metalloproteinase inhibitor GM6001 by aortic
smooth muscle cells from old mice (n=6) is reduced over 24 hours relative to those from young
mice (n=6). *P<0.05 vs young.
Discussion
Age‐related structural and cellular alterations within the aorta occur concomitantly with
biomechanical dysfunction. Accordingly, this study tested the hypothesis that alterations within
the ECM and cellular composition that occur with age directly affect the compliance and
contractility of the thoracic aorta. The findings of the present study demonstrate that aortic
diameter, thickness of the medial layer of the aortic wall, and collagen volume fraction were
higher in the older mice. Moreover, there was an age‐related decrease in cell density, aortic
compliance, and aortic contractility. Interestingly, changes in aortic compliance were correlated
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with collagen content but not with elastin content. This report demonstrates that the age‐
dependent changes in the material properties of the thoracic aorta in a murine model
contribute, at least in part, to reduced compliance and contractility of the thoracic aorta. Taken
together, these age‐related changes in aortic material properties and mechanical characteristics
may yield an aortic substrate that is more conducive to the development of aortopathies, such
as aneurysm of the thoracic aorta.
Changes in the geometry of the thoracic aorta that occur with age include aortic dilation and
increased aortic wall thickness.[53, 61] Mao et al reported that dilation of the thoracic aorta
occurred in older but healthy humans.[82] Similarly, Sonesson et al reported that there was
dilation of the abdominal aorta with increasing age.[83] Taken together, these previous studies
suggest that age‐related dilation may occur throughout the aorta. The thickness of the aortic
wall has also been reported to increase with age.[84-86] Pearson et al reported that age was
positively correlated with thoracic aortic wall thickness.[57] Consistent with these past findings,
the present study demonstrated that diameter, luminal perimeter, and wall thickness of the
thoracic aorta were increased as a function of age. Because wall stress (Laplace's law) is directly
proportional to vessel diameter, a physiological consequence of an increase in lumen diameter
is increased wall stress; therefore, wall thickness, which is inversely related to wall stress, may
have increased to normalize wall stress, as described previously in humans.[87, 88]
Consequently, this murine aging model recapitulates the morphological hallmarks of human
thoracic aortic aging and may serve as a valid model for human aortic disease.
The structure and composition of the aortic wall were examined to explore whether age‐related
morphological changes occurred concomitantly with biochemical alterations to the aortic wall.
In the present study, aortic wall collagen content increased in old mice, whereas elastin content
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remained the same between young and old mice. Moreover, both thin and thick collagen fibers
were increased in the aortas from old animals. These findings are consistent with previous
studies that reported increased collagen and collagen fiber size in the aortic walls of older rats
and humans.[61, 89] Also similar, aortic elastin content has been reported to remain unchanged
or to decrease with increasing age.[90, 91] The current study builds on these past reports by
demonstrating that an age‐dependent change in aortic collagen content was correlated with a
decrease in aortic stress relaxation. The stress relaxation of a vessel is related to its passive
compliance, and an age‐dependent decline in stress relaxation suggests that the aorta becomes
stiffer with age.[92] Moreover, the negative correlation between aortic stress relaxation and
collagen content suggests that collagen, but not elastin, is a key factor in determining the
passive compliance of the thoracic aorta. Taken together, the findings from these past reports
and the present study suggest that remodeling of the ECM within the thoracic aorta occurs as a
function of age and that this remodeling appears to be driven by selective deposition of
collagen. Importantly, increased aortic collagen in the setting of aortic dilation with age may
initially compensate for increased wall stress; however, when these compensation mechanisms
are exhausted, increases in wall stress in combination with a less compliant aorta may result in
increased susceptibility to rupture.
In addition to changes in aortic structure and ECM composition, changes in cellular composition
also occur. In the present study, the density of cells in the medial layer of the aortic wall was
decreased in old mice; this finding is consistent with past studies.[93, 94] Given that SMCs make
up most of the cellular volume of the aortic media, a functional consequence of a decrease in
cell number may be reflected as a reduction in contractility of the aortic wall.[94] Indeed, peak
contractile force in aortic rings from old mice was reduced compared with that of young mice. A
similar decline in contractility of aortic rings from old animals has been reported in rats.[72]
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Nonetheless, these ex-vivo contractility determinations do not directly delineate the
contribution of SMCs to generate contractile force. To address this issue, the present study
examined the effects of isolated SMCs on the contraction of collagen disks. In the collagen gel
contraction assay, both cellular contraction and protease degradation can act together to
reduce collagen disk area. To determine the contribution of only the contractile component,
collagen gel compaction was measured in the presence of a broad‐spectrum matrix
metalloproteinase inhibitor. Contraction of disks seeded with primary SMCs isolated from aortas
of old mice was reduced compared with that of SMCs isolated from young mice. These results
suggest an age‐dependent decline in contractile function of primary ASMCs.
Importantly, the mechanical findings of this study are aligned with previous work examining the
effects of aging on the human aorta. O'Rourke et al found that aortic stiffness, when measured
in vivo as pulse wave velocity, increased by ≈100% between the ages of 20 and 80 years.[95]
Using an intra‐aortic ultrasonic catheter, Stefanadis et al found a positive correlation between
age and the slope of the aortic pressure–diameter loop (aortic elasticity).[96] Increasing aortic
stiffness with age has also been demonstrated by Sun et al with multiphase computed
tomography imaging and through ex vivo biaxial mechanical testing of aortic specimens.[97, 98]
Results presented in this report examining aortic aging in a murine model agree with these
previous studies demonstrating a direct relationship between increased chronological age and
increased aortic stiffness such that as age increased, so did aortic stiffness.
Increased aortic stiffness has a clinically significant impact on adjacent organ systems as well as
on the aorta itself. Increased aortic stiffness, for example, is an independent risk factor for
nonfatal cardiovascular events, ischemic stroke, and renal failure.[99-101] Incorporation of
aortic compliance along with other risk factors in selected patient populations has been
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suggested as a screening tool.39 Furthermore, reduced aortic compliance is a common feature in
aortic dissection, aneurysm, and rupture that has been pathogenetically implicated because of
its deleterious effects on wall integrity.[98, 102, 103] Guidelines on addressing aortic mechanical
function clinically have been established and include pharmacological approaches to reduce the
effects of arterial stiffness, such as antihypertensive, hypolipidemic, and antidiabetic
agents.[104-107] Likewise, SMC dysfunction, which can result in reduced contractility, has been
associated with aortic aneurysm and dissection.[108] Novel approaches to ameliorate the
mechanical effects of aging on the aorta, such as microRNA therapies to modulate the aortic
ECM and smooth muscle function, have also been proposed.[109, 110] Long‐term therapeutic
trials of these pharmacological approaches should be conducted to assess the value of treating
these age‐related mechanical deficits in terms of cardiovascular risk reduction.
This study is not without limitations. First, other ECM components, including proteoglycans and
matricellular proteins, may also change with age and affect aortic mechanical properties.[90] In
addition, although the correlation between elastin content and aortic stress relaxation was not
statistically significant, a correlation of 0.28 could be meaningful in other settings and perhaps
did not attain significance because of the sample size. Second, although a reduction in cell
density with age was identified, the types of cells that were reduced were not identified. A shift
in populations of noncontractile fibroblasts or contractile myofibroblasts relative to ASMCs may
also affect aortic mechanical properties. Future studies could examine the relative abundance of
cell types using cell type–specific markers. Finally, an index of SMC contractility was assessed
using type 1 collagen disks. Care should be taken in extrapolating these results to more complex
ECM environments like those found in vivo, which are difficult to replicate with in vitro assays.
Nevertheless, the unique findings of the present study provide potential explanations for
reduced compliance and contractility with aging. In conclusion, these results have identified
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age‐related changes in geometry, ECM collagen content, and medial cellular content within the
thoracic aorta that contribute to alterations in aortic mechanical properties. Importantly, both
aortic compliance and contractility were shown to decrease with age, and this decrease may
have significant clinical implications for the risk of developing aortic disease with advanced age.

32

Chapter 5: Methods for Measuring SMC Phenotype Parameters
Overview
The goal of this study was to determine the effects of age on thoracic aortic SMC phenotype
using defined phenotypic parameters.
Animals
All procedures were performed in accordance with the National Research Council’s Guide for
the Care and Use of Laboratory Animals (2012) and approved by the institutional animal care
and use committee of the Medical University of South Carolina. C57BL6 wild-type male and
female aged 6 and 21 months were obtained from the National Institute on Aging mouse colony
at Charles River Laboratories International (Wilmington, MA, USA). Equal numbers of male and
female mice were used in each study.
Smooth Muscle Cell Isolation
Primary SMCs were isolated using an outgrowth procedure in which minced pieces of thoracic
aorta from young and old mice (6 young, 6 old) were plated in SMC-specific growth medium
(C22062; PromoCell) and allowed to extravasate for 2 weeks. After 2 weeks, the pieces of aorta
were removed, and the SMCs were maintained in culture. Cells in passages 3 to 7 were used for
all in vitro experiments.
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Proliferation Assay
An in vitro proliferation assay was performed using the Cyquant Direct Cell Proliferation Assay
Kit and manual (C35011, ThermoFisher). Briefly, cultured SMCs were seeded on to a poly-Dlysine coated, 96-well plate (354461, Corning) at 1,000 cells per well in 100ul of culture media,
in triplicate for each assay day, and allowed to adhere overnight. In addition, a standard curve of
cells was plated in duplicate to determine cell number during the proliferation period of 7 days.
After incubating overnight, 100ul of 2X detection reagent was added to the three wells
corresponding to Day 0 and standard curve wells, and then incubated for 60 minutes at 37
degrees Celsius. These wells were read from the bottom with a spectrophotometer (Spectramax
M3, Molecular Devices) at an excitation/emission of 480/535 nm and analyzed using SoftMax
Pro (version 5, Molecular Devices). In the same manner, proliferation was measured at 24 hour
intervals over the next 7 days. Results were expressed as percent increase in cells versus Day 0.
Migration Assay
An in vitro migration assay was performed using tissue-culture treated Costar Transwell 6-well
plates (3428, Corning) with polycarbonate membranes containing 8um pores. Cultured SMCs
were seeded at 50,000 cells per upper insert and allowed to adhere overnight. Afterward, cells
were incubated with 8ug/ml Mitomycin C (M4287, Sigma) in culture medium to halt
proliferation, allowing for only measurement of migrated cells. After 3 hours, the mitomycin
containing medium was removed, regular culture medium added to the upper insert, culture
medium with 10% Fetal Bovine Serum (FBS) was added to the lower well, and the cells were
allowed to migrate for 3 days. Non-migrated cells were removed from the membrane with a
sterile swab. The inserts were then placed in methanol for 5 minutes to fix the migrated cells on
the underside of the filter. The inserts were air-dried for 15 minutes and then stained with a
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1:20 solution of Giemsa stain to deionized water. The membranes were rinsed in deionized
water, allowed to dry, and then observed using a Zeiss microscope. The total number of
migrated cells in 4 high-power fields was counted per insert. Results were expressed as number
of migrated cells.
Adhesion Assay
An in vitro adhesion assay was performed using the Cyquant detection reagent used in the
proliferation assay. Cultured SMCs were seeded on to a poly-D-lysine coated, 96-well plate
(354461, Corning) at 2,000 cells per well in 100ul of culture media in triplicate and allowed to
adhere for 2 hours. The cells were washed 3 times with PBS containing calcium and magnesium
using the Bio-Plex Pro II Wash Station (Bio-Rad) for consistency. Afterward, washed wells were
labeled with 100ul of Cyquant detection reagent and culture media in a 1:1 ratio and incubated
for 60 minutes at 37 degrees Celsius. These wells were read from the bottom with a
spectrophotometer (Spectramax M3, Molecular Devices) at an excitation/emission of 480/535
nm and analyzed using SoftMax Pro (version 5, Molecular Devices). The washed wells were
compared to corresponding unwashed wells, also seeded in triplicate using the same
fluorescent labeling method. Results were presented as a percent of adhered cells relative to
unwashed wells.
Gene Expression by PCR Array and Radar Plot Profile
RNA was isolated from cultured thoracic aortic SMCs using the RNeasy Mini Kit (74106, Qiagen)
according to the Fourth Edition of the RNeasy Mini Handbook. RNA quality and concentration
was measured using the Agilent RNA 6000 Nano Kit (5067-1511) and Agilent 2100 Bioanalyzer.
For each sample, 1ug RNA was converted to cDNA with iScript (170-8891, Bio-Rad) and then
loaded onto custom, murine-specific RT2-Profiler PCR Array (CAPM09716D, SABiosciences) per
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the array user manual. The arrays were read using a Bio-Rad CFX96 plate-reader according to
the protocol described in the SABiosciences Technical Note for Software version 1.6. Expression
was calculated using the delta-CT method and results were expressed in a radar plot profile as
the relative fold increase in expression of three groups of genes: ECM proteins, matrix
metalloproteinases (MMPs), and tissue inhibitors of MMPs (TIMPs). Primer specificity was
confirmed by performing a melt curve with each array.
Statistical Analysis
All results are presented as mean ± SEM. The Student t-test was used to compare
measurements of aortic SMC migration and adhesion between young and old groups. Pairwise
comparison was used to compare proliferation over 7 days between experimental groups. All
statistical analyses were performed using Stata statistical software (version 8, intercooled;
StataCorp). P values of <0.05 were considered to be statistically significant.
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Chapter 6: Aortic SMC Phenotype is Not Stable with Age
Introduction
The thoracic aorta undergoes geometric and mechanical changes with age, including dilation
and stiffening in association with increased collagen in the aortic wall.[61, 111] These agerelated alterations are not benign. Indeed, increased aortic stiffness is now recognized as a
clinically relevant risk factor for cardiovascular disease.[112] In the setting of normal aging,
resident cells within the aortic wall likely mediate these age-related changes. Whether aged
resident cells initiate, or react to, the aortic aging process is not clear. In either case, aortic cell
phenotype would be expected to be altered with age. While age-associated alterations in aortic
geometry and mechanical function at the tissue-level have been well-described, changes in
aortic cell phenotype with age have received relatively little attention.
Smooth muscle cells (SMCs) are the most abundant cell type in the aortic media, the vessel layer
which bears the largest share of hemodynamic stress.[113]

These cells perform several

functions that mediate aortic geometry and function, including contraction and extracellular
matrix (ECM) remodeling, and are critical mediators of aortic integrity. Thus, an age-associated
shift in the phenotype of aortic SMCs could impact both passive and active mechanical
function.[114] Indeed, alteration in SMC phenotype has been reported in several aortopathies.
Changes in aortic SMC phenotype have been described in association with mutations in
transforming growth factor – beta receptors (TGFBR) and fibrillin-1, which cause Loeys-Dietz
syndrome and Marfan syndrome, respectively.
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In aortic SMCs from patients with TGFBR

mutations, decreased expression of contractile genes has been asserted to cause defective
contractile function and contribute to aneurysm pathogenesis.[115] While SMCs from dilated
aortas of Marfan syndrome patients, demonstrated increased expression of contractile genes
that was believed to contribute to aneurysm pathogenesis by increasing aortic stiffening .[116]
In both syndromes, an alteration in SMC phenotype was pathologically implicated.
Cellular phenotype can be defined by multiple parameters of cell behavior and structure. In the
context of aging, several phenotype parameters may contribute to structural and functional
changes within the aorta, including proliferation, migration, adhesion, and gene expression of
ECM remodeling genes. A better understanding of how these parameters are altered with age
may provide insight into cell-mediated mechanisms of aortic aging, as well as potentially inform
our understanding of the role of aging in aortopathies. Therefore, our study compared these
specific phenotype parameters in aortic SMCs isolated from young and old mice to test the
hypothesis that aging results in an altered aortic SMC phenotype.
Results
Thoracic Aortic SMC Proliferation is Decreased with Aging
Proliferation over a 7 day period was assessed using a fluorescent DNA-binding dye and found to
be significantly decreased in aortic SMCs from the old group compared to those from the young
group (Figure 6.1). This difference became statistically significant on Day 5 and persisted
through Day 7. The typical sigmoidal appearance of the young aortic SMC proliferation curve is
in contrast to the old aortic SMC proliferation curve, which has a flattened sigmoid appearance.
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Figure 6.1 Thoracic aortic SMC proliferation is decreased with aging. Proliferation was decreased
in aortic SMCs from old mice (n=6, yellow circles) compared to those from young (n=6, green
circles). *P<0.05 vs. Young.
Thoracic Aortic SMC Migration is Decreased with Aging
Representative high-power fields of fixed, Giemsa-stained SMCs (blue) from young and old mice
that have migrated to the side of the membrane containing culture media with 10% FBS added
as a chemoattractant are shown (Figure 6.2, Top Panel). After mitotic-inhibition with mitomycin
C and a 3 day incubation period, quantification of the number of aortic SMCs that had migrated
through a porous (8 micron diameter) membrane revealed that migration was significantly
decreased in old SMCs relative to young SMCs (Figure 6.2, Bottom Panel).
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Figure 6.2 Thoracic aortic SMC migration is decreased with aging. Representative high-power
fields of Giemsa-stained, young and old aortic SMCs that have migrated through a porous
membrane. Migration was decreased in aortic SMCs from old mice (n=6, yellow) compared to
those from young (n=6, green). *P<0.05 vs. Young.
Thoracic Aortic SMC Adhesion is Decreased with Aging
Adhesion of aortic SMCs to a tissue-culture treated, poly-D-lysine coated 96-well plate was
assayed using a fluorescent DNA-binding dye. After automated washing, the percent adherence,
as measured by remaining fluorescence relative to unwashed wells, was significantly reduced in
aortic SMCs isolated from old mice relative to those from young mice (Figure 6.3).
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Figure 6.3 Thoracic aortic SMC adhesion is decreased with aging. Adhesion to a tissue-culture
treated surface after automated washing was decreased in aortic SMCs from old mice (n=6,
yellow) compared to those from young (n=6, green). *P<0.05 vs. Young.
Thoracic Aortic SMC Gene Expression Profile with Aging
If an SMC phenotype shift occurs with age, a change in gene expression would be expected.
Given that our previously published data indicated an increase in aortic wall collagen content
with age that correlated with vessel compliance, the expression of ECM remodeling genes was
examined using a PCR array to determine whether the aortic SMC population may contribute to
these age-related ECM and mechanical changes (Table 6.1). A gene expression profile was
generated incorporating ECM remodeling genes on the array into three categories: ECM
proteins, matrix metalloproteinases (MMPs), and tissue inhibitors of MMPs (TIMPs). These
categories were graphed in a radar plot to show fold changes in gene expression relative to the
young group and demonstrated a distinct expression profile in old aortic SMCs (Figure 6.4),
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suggesting that a shift in SMC phenotype contributes to aortic ECM and mechanical changes
with age. Interestingly, the stromelysin MMPs (MMP-3 and MMP-11) were increased
significantly with age.
Table 6.1 Table of ECM Remodeling Genes Examined by PCR Array.
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Figure 6.4 Gene expression profile of ECM remodeling genes with aging. Radar plot of the
relative fold increase in expression of three groups of ECM remodeling genes: ECM proteins
(ECM), matrix metalloproteinases (MMPs), and tissue inhibitors of MMPs (TIMPs), in old aortic
SMCs (n=6, yellow triangle) compared to young aortic SMCs (n=6, green triangle).

Collagen Isoform Expression Increases with Age
Several collagen alpha chain isoforms were included within the “ECM” group of the PCR array,
including collagen 1a1, 1a2, 3a1, 4a1, 5a1 and 6a1. The gene expression levels of all of these
collagen alpha chains, except 5a1, were increased in old aortic SMCs compared to young (Figure
6.5).
Expression of TGF- β Signaling Pathway Components Increases with Age
Increased fibrotic signaling in aortic SMCs with age could be responsible for increased ECM
protein expression. To evaluate whether this was the case, the expression levels of several
mediators of TGF- β signaling, which has been reported to increase in whole aortas with age,
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were compared between young and old aortic SMCs.

Expression of TGF-β Receptor Type 1,

TGF-β Receptor Type 2, Smad2, and Smad4 was increased in old aortic SMCs (Figure 6.6).

Figure 6.5 Aortic SMC collagen isoform expression with aging. Fold expression of multiple
collagen isoforms increased in aortic SMCs with age (n=6, yellow bars) relative to young SMCs
(n=6, green line). *P<0.05 vs. Young.
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Figure 6.6 Expression of TGF-β signaling pathway components with aging. Gene expression
levels of TGF-β Receptor Type 1/Tgfbr1 (Panel A), TGF-β Receptor Type 2/Tgfbr2 (Panel B),
receptor Smad2 (Panel C), and common Smad4 (Panel D) were increased in old aortic SMCs
(n=6, yellow bar) compared to young aortic SMCs (n=6, green bar). *P<0.05 vs. Young

Discussion
This set of studies tested whether thoracic aortic SMC phenotype is altered by aging. Phenotype
was defined by the following parameters: proliferation, migration, adhesion, and gene
expression. Using in vitro assays to assess these parameters, isolated aortic SMCs from old mice
demonstrated reduced proliferation, migration, and adhesion, relative to those from young
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mice. In accordance with a change in phenotype, isolated aortic SMCs from old mice also
exhibited a distinct gene expression profile consistent with increased ECM remodeling.
Together, these studies support the conclusion that aortic SMC phenotype is not stable with
age. Furthermore, the age-related changes in SMC phenotype parameters are consistent with
the aortic structural and mechanical alterations previously described with age, suggesting this
cell population contributes, in part, to aortic aging.[114] Overall, these results represent one of
the first literature reports of thoracic aortic aging at the cellular level.
While previous reports on aortic aging largely describe a decline in compliance in association
with increased collagen, diameter, and wall thickness, little has been published on which
resident cell population may contribute to this age-related remodeling.[61, 111] For example,
though publications describe the decline in aortic medial cell content with age, the means by
which this occurs has not been well-studied. In this study, we found that in vitro proliferation of
SMCs from old mice exhibited decreased proliferation relative to those from young mice. This
finding is in contrast to studies that used aortic SMCs isolated from aged rat models to examine
SMC proliferation with age.[117, 118] However, other studies using primary SMCs from rats and
other species have produced contrasting data suggesting proliferation is reduced with age.[119]
This conflicting data may be due to variation in model species, models of vascular injury,
isolation methods, and methodology.[120] Importantly, our findings are consistent with studies
that used aortic SMCs isolated from C57BL/6 mice and humans, which demonstrated decreased
proliferation with age.[121-124] Furthermore, in patients over 70, restenosis due to SMC
proliferation after carotid endarterectomy was less common than in younger patients,
suggesting that aged SMCs may have a reduced capacity to proliferate and completely restore
their population after injury or death.[125] Our result, together with previous murine and
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human data from other investigators, suggests that aortic SMC proliferation is reduced with age
and may contribute to the decline in aortic medial cell content with age.
After proliferation, migration is the most commonly reported SMC phenotype parameter.
Previously, we published that aortic SMCs from aged mice have reduced contractility.[114]
Given that contractility is a necessary component of motility, SMC migration was expected to be
reduced with age. Our study examined migration using a Boyden chamber with serum as a
chemoattractant, and indeed, migration was reduced in aortic SMCs from aged mice. Like
proliferation, a majority of migration studies have been performed using primary cells from rats,
which report increased migration with age.[120, 126, 127] However, a study using aged human
SMCs in a Boyden chamber demonstrated decreased migration with age, in agreement with our
findings. Such contradicting proliferation and migration results in humans emphasize the need
for caution when extrapolating from rat SMC studies. Further complicating interpretation of
these studies is that the methods to study migration are quite varied and include gel invasion
assays, scratch/wound assays, and Boyden chamber assays. Each of these methods examine
distinct aspects of migration and care should be employed when comparing them.[128] Overall,
our finding of reduced SMC migration with age further supports our previously published
findings on SMC contractility with age and suggests aged SMCs may be less able to migrate
within the aorta if needed.
The effect of aging on SMC adhesion has not been examined to the extent that proliferation and
migration have been in the literature. The majority of articles on adhesion and the aging
vasculature report an increase in the expression and abundance of adhesion molecules, such as
vascular cell adhesion molecule-1 VCAM-1. Most of these studies refer to these adhesion
molecules in the context of inflammatory cell adhesion and infiltration. Few studies have
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focused on the ability of SMCs to remain attached to its substrate under stress. In this study,
fewer old SMCs remained adherent to their underlying substrate after washing relative to young
SMCs. In a similar study, atomic force microscopy was used to examine the adhesion force of rat
aortic SMCs to fibronectin coated microbeads. Adhesion force per cell increased with age.[129]
However, this method employed a single, specific substrate to assess adhesion, whereas the
washing method evaluates adhesion strength onto a matrix produced by SMCs. Both results may
reflect a shift in integrin subtype abundance on the SMC surface with age, which has been
previously suggested.[117, 130] Such a shift may have significant consequences on cell
phenotype and contractile function.[117, 130, 131]
Lastly, if an age-related shift in SMC phenotype occurs, a change in the profile of genes
expressed would be expected. Because of the increase in aortic wall thickness and collagen
content with age, we chose to examine three groups of ECM remodeling genes - matrix
metalloproteinases (MMPs), tissue inhibitors of MMPs (TIMPs), and ECM proteins. Aged aortic
SMCs exhibited a distinct gene expression profile consistent with a greater role for SMCs in
vascular remodeling. Increased collagen expression, which may be due to elevated expression
levels of multiple TGF-β signaling pathway components, by old aortic SMCs suggests that this
cell type contributes to increased aortic wall thickness and decreased compliance with age. This
finding, in combination with decreased contractility, suggests that SMCs undergo a functional
shift with age and contribute to passive and active mechanical dysfunction of the aorta.
Importantly, increased aortic stiffness due to elevated collagen content has been reported to
raise arterial pulse pressure, which in turn increases cardiac work and decreases downstream
organ perfusion. Thus, a shift in aortic SMC phenotype with age may also impact cardiovascular
disease risk. However, this has yet to be demonstrated experimentally.
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While this study provides evidence that aortic SMCs undergo a phenotype shift with age and
suggests this cell population participates in the hallmarks of aortic aging, it is not without its
limitations. This study focused on the impact of age on aortic SMCs. While this is the most
abundant cell type within the aorta, other resident cell types, such as fibroblasts and endothelial
cells, could play significant roles in aortic aging and were not evaluated in this study.
Furthermore, these cell populations likely interact and influence the other’s behavior.
Therefore, future studies examining the impact of aging on these cell types and their
interactions are necessary to better understand the cellular mechanisms of aortic aging.
Moreover, mechanical and environmental inputs from the ECM also influence SMC
phenotype.[132-134] The in vitro studies used here serve to illustrate phenotypic differences
due to aging but do not necessarily reflect in vivo behavior, as the complex in vivo environment
(wide variety of ECM proteins, mechanical cues, etc) is not easily replicated. Thus, caution
should be employed when generalizing these results to in vivo SMC phenotype. In addition, the
influence of other age-related factors on the results of our phenotype studies cannot be
excluded. For example, it has been reported that SMCs differentially respond to certain growth
factors with age.[135, 136] Decreased SMC proliferation and migration with age may be the
result of an attenuated response to the serum growth factors used in these studies. Thus, an
increase or decrease in these phenotype parameters with age may be dependent on which
specific growth factors are used in these assays and may perhaps explain some of the conflicting
results reported by other investigators. Nevertheless, this data provides evidence that aortic
SMC phenotype is not stable with age and such a phenotype shift likely contributes to changes
in aortic structure and mechanical function.
Future studies will investigate the age-related mechanisms regulating SMC phenotype and
whether manipulation of SMC phenotype translates to alterations in aortic structure and
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mechanical function in vivo. If aortic mechanical dysfunction with age can be attenuated by
inhibiting the age-associated phenotype shift, subsequent studies performed in animal models
of aortic disease, such as aneurysm, could examine the contributions of an aged aortic substrate
to its pathogenesis.
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Chapter 7: Summary and Future Directions
The studies described by this thesis provide supporting results for a non-transgenic mouse
model of thoracic aortic aging. Importantly, mechanical studies in this model identified a novel
age-related contractile deficit in ex vivo aortic segments after depolarization with potassium,
which had not been previously described in the literature. Further, an innovative variation of
the collagen gel contraction assay in the presence of a broad MMP inhibitor indicated that the
contractile deficit was present at the level of the individual smooth muscle cell, suggesting that
decreased aortic contractility with age may be due to both a decrease in cellular density within
the aortic wall and a decrease in smooth muscle cellular contractility. This decrease in
contractility suggested that SMC phenotype may have been affected with age. Subsequent
studies of phenotype parameters implicated a phenotype shift in aortic SMCs with age.
Moreover, the results of the phenotype studies were congruent with age-related structural and
mechanical changes observed histologically and with ex-vivo studies in the aged mouse model.
For example, decreased aortic SMC proliferation was congruent with decreased cell density
within the aortic wall histologically. Likewise, decreased adhesion and migration with age was
consistent with the finding of decreased cellular contractility. Additionally, increased expression
of collagen alpha chains and an altered gene expression profile are consistent with the observed
increase in aortic collagen, wall thickness and stiffness with age. Together, these studies
collectively provide support that aortic smooth muscle cells mediate age-related aortic
structural and mechanical alterations, in part, through a shift in phenotype. Whether this
phenotype shift initiates age-related changes within the aorta or develops as a consequence of
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these changes, it not yet known and requires further study. Regardless, these results support
that aged aortic smooth muscle cells contribute to aortic aging through increased collagen
within a thickened aortic wall leading to decreased compliance, as well as decreased cell density
and contractility that may result in dilation.
A phenotype shift in aortic SMCs with age offers an intriguing mechanism with the potential to
unify several age-associated aortic changes. It is interesting to speculate that an aortic SMC
phenotype shift could explain both aortic stiffening and dilation with age. Importantly, while
aortic dilation with age has been described, the mechanism behind this dilation has not been
well studied. It may be that a phenotype shift results in both decreased cell density, through
decreased proliferation, and reduced contractility. Together, this reduction in the number of
SMCs and their ability to contract to regulate aortic diameter, may explain aortic dilation with
age. Furthermore, as a compensatory mechanism in response to increased wall stress, the aged
SMCs may produce more collagen in order to normalize wall stress through increased wall
thickness. Thus, a phenotype shift in aortic SMCs could be a potential mechanism for both
increased aortic dilation and stiffness with age (Figure 7.1). However, further studies are
needed to support this mechanism.
Interestingly, altered ECM composition itself as a result of a phenotype shift may induce or
maintain cellular phenotype shifts. Indeed, a change in basement membrane proteins with age
could produce an altered SMC phenotype. It has been reported that a basement membrane
composed of laminin aids in maintaining a “contractile” SMC phenotype, while a basement
membrane composed primarily of fibronectin results in a “synthetic” SMC phenotype. The role
of these basement membranes in aortic SMC phenotype shift has not been fully examined but
remains a valid avenue of investigation. Additionally, SMC phenotype may also be regulated not

52

only by the proteins to which the SMCs adhere but also by the adhesion proteins linking the
ECM to the SMC membrane, e.g. integrins. Together, SMCs may interpret extracellular cues
from both specific ECM proteins and integrins that mediate attachment to mechanically sense
their environment. Indeed, it is intriguing to speculate that with age the abundance of both
ECM proteins and integrins are altered in a manner that results in altered SMC phenotype. If so,
mechanotransduction – the signaling process by which extracellular mechanical stimuli are
transduced into the cell and incorporated into a cellular response – may be altered with age as
well. Of note, dysregulated mechanotransduction has been proposed as a potential unifying
mechanism for aortic aneurysm development based on associations with mutations in several
mechanotransduction proteins, including smooth muscle actin. Smooth muscle actin is a
component necessary for contractility and has also been used as a marker for phenotype shifts.
Thus, whether through altered contractility, ECM proteins, or integrin abundance with age,
aortic mechanotransduction may be disturbed in a such a way that predisposes to aneurysm
development.
Future experiments may examine the role of TGF- signaling in regulating the phenotype
parameters examined, including proliferation, migration, adhesion, gel contraction, and gene
expression. It may be that TGF- signaling regulates some, but not all, of the parameters
studied, implying that age-related SMC phenotype modulation is complex. Given that the aged
phenotype was observed in association with increased expression of canonical TGF- signaling
receptors and mediators, methods to inhibit this pathway, such as TGF- neutralizing antibody,
could be used in vitro in an attempt to modulate parameters. It would be interesting to
speculate that a “young” phenotype could be restored with TGF- inhibition in SMCs from old
aortas. Of special interest would be the role of TGF- signaling in mediating gel contraction. A
previous report demonstrated that TGF- stimulation in VSMCs increases expression of
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contractile proteins, which would be expected to increase gel contraction. Perhaps, TGF-
signaling has a differential influence with age, such that increased stimulation in old SMCs
results in reduced contractile protein expression and reduced gel contraction. Alternatively,
increased TGF- signaling in old SMCs may impair contractility via pathways independent of
contractile protein expression.

Figure 7.1 Summary: A New Understanding of Aortic Aging. An SMC phenotype shift with age,
potentially due to increased TGFB signaling, results in both decreased cell density, through
decreased proliferation, and reduced contractility. Together, this reduction in the number of
SMCs and their ability to contract to regulate aortic diameter, may explain aortic dilation with
age. As a compensatory mechanism in response to increased wall stress, the aged SMCs may
produce more collagen in order to normalize wall stress through increased wall thickness,
resulting in a more stiff and brittle aorta. Thus, a phenotype shift in aortic SMCs could be a
potential mechanism for both increased aortic dilation and stiffness with age., in addition to
resulting in mechanical dysfunction, cardiovascular and aortopathy risk. TGFB, Transforming
Growth Factor-Beta; SMC, Smooth Muscle Cell; Yellow circles, Aged Aortic Smooth Muscle Cells;
Curved Black Lines, Collagen.
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